ADMA Biologics Reports Q3 2026 Earnings: EPS of $0.22 and Revenue of $141.1M Beat Estimates
GAAP EPS of $0.22 and Revenue of $141.1 Million Top Analyst Expectations; FY2026 Earnings Outlook Raised Related Stocks: ADMA ,
GAAP EPS of $0.22 and Revenue of $141.1 Million Top Analyst Expectations; FY2026 Earnings Outlook Raised Related Stocks: ADMA ,